Ad
related to: which specialty treats pulmonary hypertension treatment
Search results
Results from the WOW.Com Content Network
Treatment of pulmonary hypertension is determined by whether the PH is arterial, venous, hypoxic, thromboembolic, or miscellaneous. If it is caused by left heart disease, the treatment is to optimize left ventricular function by the use of medication or to repair/replace the mitral valve or aortic valve. [68]
A pulmonary artery wedge pressure being less than 15 mmHg (also measured by right heart catheterization) excludes post-capillary bed (in the veins distal to the capillary bed) pulmonary hypertension. Pulmonary arterial hypertension is a subgroup of pulmonary hypertension and is categorized as World Health Organization as group 1. [3]
Chronic thromboembolic pulmonary hypertension (CTEPH) is a long-term disease caused by a blockage in the blood vessels that deliver blood from the heart to the lungs (the pulmonary arterial tree). These blockages cause increased resistance to flow in the pulmonary arterial tree which in turn leads to rise in pressure in these arteries ...
Researchers from The University of Arizona College of Medicine Tucson suggest that hormone replacement therapy (HRT) may improve pulmonary hypertension in females. Scientists believe the hormone ...
Researchers say dietary changes that limit the amino acids glutamine and serine may help slow disease progression in pulmonary hypertension and improve the effectiveness of current medications.
Pulmonology (/ ˌ p ʌ l m ə ˈ n ɒ l ə dʒ i /, / ˌ p ʊ l m ə ˈ n ɒ l ə dʒ i /, from Latin pulmō, -ōnis "lung" and the Greek suffix -λογία-logía "study of"), pneumology (/ n ʊ ˈ m ɒ l ə dʒ i, n j ʊ-/, built on Greek πνεύμων pneúmōn "lung") or pneumonology [1] (/ n ʊ m ə n ˈ ɒ l ə dʒ i, n j ʊ-/) is a medical specialty that deals with diseases involving ...
Surgery is indicated in patients with pulmonary artery emboli that are surgically accessible. Thrombi are usually the cause of recurrent/chronic pulmonary emboli and therefore of chronic thromboembolic pulmonary hypertension (CTEPH). [2] PTE is the only definitive treatment option available for CTEPH. [3]
Iloprost, sold under the brand name Ventavis among others, is a medication used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon, frostbite, and other conditions in which the blood vessels are constricted and blood cannot flow to the tissues. [4] Iloprost is a prostacyclin mimetic. [1]
Ad
related to: which specialty treats pulmonary hypertension treatment